"当センターは宮城県におけるがん治療の拠点として、高度な診療機能を確保しています。 「患者さんの視点に立ち、良質かつ先進的医療を提供し、がん専門病院としての使命を果たす」 という基本理念のもとに医療を行っております。"

During the past decade, Miyagi Cancer Center; Respiratory Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Miyagi Cancer Center; Respiratory Medicine" are "Non-Squamous Non-Small Cell Lung Cancer" (2 trials), "Adult Solid Tumor" (1 trials), "Breast Cancer" (1 trials), "Cholangiocarcinoma" (1 trials) and "Colorectal Cancer" (1 trials). Many other conditions were trialed in "Miyagi Cancer Center; Respiratory Medicine" in a lesser frequency.

Most popular intervention types in "Miyagi Cancer Center; Respiratory Medicine" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (2 trials), "Atezolizumab" (1 trials), "Bevacizumab" (1 trials), "Entrectinib" (1 trials) and "Erlotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Miyagi Cancer Center; Respiratory Medicine" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Miyagi Cancer Center; Respiratory Medicine". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Miyagi Cancer Center; Respiratory Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Miyagi Cancer Center; Respiratory Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".